Why Replication Reports Need More Than a P-Value
A replication result is most informative when readers can assess both the estimated effect and its uncertainty in each cohort, as well as the overall evidence across cohorts. A single pooled p-value cannot show whether estimates agree, whether one cohort dominates the synthesis, or whether the pooled effect is precise enough to be useful. In multi-omics work, the report must also make clear which features or hypotheses were tested and how multiplicity was handled.
The reporting goal is not to make results look consistent. It is to show the evidence transparently, including imprecision, heterogeneity, and outcomes that do not meet the planned replication criteria. The criteria should be stated in advance and linked to the scientific claim: for example, requiring a matching direction of effect, an effect exceeding a specified minimum, or evidence that survives adjustment across a defined family of tests.
What to Report for Each Cohort and for the Synthesis
For each cohort, report the effect estimate, its unit or scale, a confidence interval, and—when relevant—the standard error and sample size. State the outcome contrast and direction clearly. For example, a coefficient of \(0.30\) might mean a \(0.30\)-unit higher outcome per one-unit increase in a molecular feature, whereas a log odds ratio is interpreted on a different scale. If estimates have been transformed, say so and report the scale used for both synthesis and interpretation.
A conventional \(100(1-\alpha)\%\) confidence interval describes the long-run coverage of the interval procedure under its model assumptions. It does not mean there is a \(100(1-\alpha)\%\) probability that the fixed parameter lies in the particular observed interval. Readers should be able to see whether each cohort’s estimate is compatible with a range of effects, not just whether its individual test crossed a significance threshold.
For the pooled result, identify the model, the estimation method, the number of cohorts, and the pooled estimate with its confidence interval. If a fixed-effect model is used, explain that it targets a common underlying effect across cohorts. If a random-effects model is used, explain that it allows cohort effects to vary and targets the mean of an assumed distribution of effects. Report a heterogeneity summary alongside the pooled result rather than using the pooled interval as a substitute for that information.
Worked Example: Reporting Cohort Estimates and a Fixed-Effect Summary
Suppose three hypothetical validation cohorts estimate the difference in a molecular outcome, in log2 expression units, between two treatment groups. The estimates and standard errors are: cohort A, \(0.40\) and \(0.15\); cohort B, \(0.25\) and \(0.12\); cohort C, \(0.55\) and \(0.20\). Assume the estimates are approximately normal, independent across cohorts, and target the same underlying contrast. For this illustration, use two-sided 95% Wald intervals and an inverse-variance fixed-effect synthesis.
For a cohort estimate \(\hat{\theta}_i\) with standard error \(SE_i\), the 95% Wald interval is \(\hat{\theta}_i \pm 1.96SE_i\). Thus cohort A’s interval is \(0.40 \pm 1.96(0.15)=0.40 \pm 0.294\), or \(0.106\) to \(0.694\) log2 expression units. Cohort B’s interval is \(0.25 \pm 1.96(0.12)=0.25 \pm 0.235\), or \(0.015\) to \(0.485\). Cohort C’s interval is \(0.55 \pm 1.96(0.20)=0.55 \pm 0.392\), or \(0.158\) to \(0.942\).
The fixed-effect weights are \(w_i=1/SE_i^2\): \(w_A=44.44\), \(w_B=69.44\), and \(w_C=25.00\). The pooled estimate is the weighted mean:
Its standard error is \(SE_{FE}=\sqrt{1/\sum_iw_i}=\sqrt{1/138.89}=0.0849\). The 95% interval is \(0.352 \pm 1.96(0.0849)\), or \(0.186\) to \(0.518\) log2 expression units. A clear report would give all three cohort estimates and intervals, then state that the fixed-effect pooled estimate was \(0.352\) log2 units (95% CI \(0.186\) to \(0.518\)), based on three cohorts and the stated common-effect assumption. This summary does not, by itself, establish that the effects are identical across cohorts.
Heterogeneity and the Choice of Pooled Result
A pooled estimate can be reported under a fixed-effect or random-effects model, but the interpretation differs. A fixed-effect analysis assumes that all cohorts share one true effect and that observed differences arise from sampling error. A random-effects analysis assumes cohort effects vary around a distribution, commonly modeled as normal with mean \(\mu\) and between-cohort variance \(\tau^2\). Both require that cohort estimates are sufficiently comparable in their estimand and that their uncertainty estimates are valid. Independence between cohorts is also ordinarily assumed for the simple formulas.
A common heterogeneity summary is Cochran’s \(Q=\sum_i w_i(\hat{\theta}_i-\hat{\theta}_{FE})^2\). Under a common-effect model and its regularity conditions, \(Q\) is compared with a chi-square distribution with \(k-1\) degrees of freedom, where \(k\) is the number of cohorts. The \(I^2\) statistic summarizes the proportion of observed variation in estimates attributed to heterogeneity rather than sampling error, using \(I^2=\max(0,(Q-(k-1))/Q)\times100\%\) when \(Q>0\). Neither statistic fully describes the size or practical importance of between-cohort differences. In particular, \(I^2\) can be imprecise when few cohorts are available.
Worked Example: Reporting Heterogeneity and a Random-Effects Estimate
Consider three hypothetical cohorts with estimates \(0.10\), \(0.50\), and \(0.90\) outcome units, each with standard error \(0.10\). Assume independent estimates on the same scale. The fixed-effect weights are all \(1/0.10^2=100\), so the fixed-effect estimate is \((100(0.10)+100(0.50)+100(0.90))/300=0.50\).
The heterogeneity statistic is
There are \(k-1=2\) degrees of freedom. Therefore \(I^2=(32-2)/32\times100\%=93.75\%\), indicating substantial observed inconsistency relative to sampling error in this example. This is not a measure of the absolute size of the effects’ differences, and it does not prove that a particular source caused the inconsistency.
For illustration, estimate \(\tau^2\) with the DerSimonian–Laird moment estimator. With equal weights, \(C=\sum_iw_i-\sum_iw_i^2/\sum_iw_i=300-30000/300=200\), so \(\hat{\tau}^2=(Q-(k-1))/C=(32-2)/200=0.15\). The random-effects weights are \(w_i^*=1/(0.01+0.15)=6.25\). Since these weights are equal, the random-effects estimate is \(0.50\), and its standard error is \(\sqrt{1/(3(6.25))}=0.231\). A normal-approximation 95% interval is \(0.50 \pm 1.96(0.231)\), or \(0.047\) to \(0.953\) outcome units. A report should name the variance estimator and interval method, as well as the result; a different estimator or small-sample interval method can produce a different interval.
The example also shows why a pooled estimate should not conceal cohort-specific results. The estimated mean effect is \(0.50\), but the cohort estimates range from \(0.10\) to \(0.90\). A random-effects interval describes uncertainty about the mean under its model; it is not a prediction interval for the effect in a new cohort. When prediction is important, report a suitable prediction interval if the number of cohorts and method support it, and explain its additional uncertainty.
Multiplicity and Explicit Replication Criteria
In a multi-omics validation, many features, pathways, signatures, or contrasts may be assessed. A report must define the family of tests to which multiplicity control applies, state the procedure, and report adjusted evidence or clearly identified adjusted thresholds. A procedure such as Bonferroni controls the family-wise error rate under arbitrary dependence by testing each of \(m\) hypotheses at level \(\alpha/m\), or by reporting adjusted p-values \(\min(mp,1)\). Other procedures may target a different error rate; the target and procedure must be named.
Multiplicity-adjusted p-values do not automatically make ordinary 95% confidence intervals simultaneous. If intervals are used to make family-wise claims, report intervals constructed with a compatible adjustment, or label ordinary intervals as unadjusted descriptive intervals. Similarly, a statistically significant result is not automatically a successful replication. Criteria may require several conditions, such as the same direction as the discovery estimate, an adjusted p-value below a threshold, and a validation estimate exceeding a pre-specified minimum effect. The report should identify each condition and evaluate it separately.
Worked Example: Multiplicity and a Pre-Specified Replication Rule
Suppose a hypothetical validation examines four pre-specified molecular features as one family, using Bonferroni control at family-wise \(\alpha=0.05\). Their unadjusted p-values are \(0.003\), \(0.018\), \(0.041\), and \(0.20\). The adjusted p-values are the smaller of 1 and four times each value: \(0.012\), \(0.072\), \(0.164\), and \(0.800\). Only the first feature meets the adjusted significance threshold of \(0.05\).
For that first feature, assume the validation estimate is \(0.40\) log2 expression units with standard error \(0.15\), and the discovery estimate was positive. A pre-specified replication rule requires (1) a positive validation estimate, (2) Bonferroni-adjusted \(p<0.05\), and (3) a validation estimate of at least \(0.30\) log2 units. The estimate meets the direction rule because \(0.40>0\), meets the adjusted significance rule because \(0.012<0.05\), and meets the minimum-effect rule because \(0.40\geq0.30\). It therefore meets all three stated criteria.
Its ordinary 95% interval is \(0.40\pm1.96(0.15)\), or \(0.106\) to \(0.694\) log2 units. This is an unadjusted interval. If simultaneous intervals for all four features were required using the Bonferroni method, each interval would have confidence level \(1-0.05/4=0.9875\), with critical value approximately \(2.498\). For the first feature that interval is \(0.40\pm2.498(0.15)=0.40\pm0.375\), or \(0.025\) to \(0.775\) log2 units. The report must not describe the ordinary interval as multiplicity-adjusted.
Diagnostics, Alternatives, and Common Reporting Failures
Before interpreting a synthesis, check that the cohorts estimate a sufficiently comparable scientific contrast, that effect directions and transformations are consistent, and that reported standard errors reflect the analysis actually used. Inspect cohort-specific estimates and intervals for outliers or patterns tied to assay, population, or design. Such patterns can motivate sensitivity analyses, but should not be presented as causal explanations without evidence. Check whether the chosen synthesis is sensitive to one cohort, using a leave-one-cohort-out summary when appropriate, and state whether the conclusion changes.
Fixed-effect synthesis is most interpretable when a common effect is scientifically plausible and supported by the design. Random-effects synthesis is often more appropriate when true effects can vary, but it does not repair incompatible estimands or remove bias. Reporting every cohort separately without pooling is a reasonable alternative when pooling is not justified, although it may be less precise as a summary. Reporting only a pooled estimate is usually inadequate when heterogeneity or transportability matters. These approaches answer different questions; no model choice should be made solely because it produces a preferred p-value.
- Pitfall: “The replication succeeded because the p-value was below 0.05.” A p-value alone does not assess direction, effect magnitude, multiplicity, or the pre-specified replication claim. Apply and report each criterion separately.
- Pitfall: “The cohort intervals overlap, so there is no heterogeneity.” Visual overlap is not a formal heterogeneity assessment, and non-overlap is not a complete substitute for one. Report a named heterogeneity measure and inspect the estimates in context.
- Pitfall: reporting only the pooled estimate. This can hide opposing or widely varying cohort estimates. Show cohort-specific estimates and intervals alongside the model-based summary.
- Pitfall: calling an adjusted p-value a probability that the finding is true. An adjusted p-value is not the probability that the null hypothesis is true; it is evidence summarized under a testing procedure and its assumptions.
A useful report also states when a result is inconclusive. Failure to meet a criterion can reflect an estimate in the wrong direction, insufficient precision, a multiplicity-adjusted result above threshold, or a minimum effect not attained. Those outcomes are not interchangeable. Reporting which condition failed, with the estimate and interval, gives readers a more accurate account than labeling the entire analysis simply “negative.”
Name the feature or hypothesis, effect scale, direction, and replication criteria before presenting the result.
Give each cohort’s estimate and confidence interval, along with relevant sample sizes and units.
Name the pooling model, uncertainty method, multiplicity family and procedure, and heterogeneity measures.
State which pre-specified conditions were met, not met, or not assessable; avoid reducing the conclusion to one p-value.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- Two cohorts estimate effects of \(0.20\) and \(0.60\) units. Why is reporting only their pooled estimate insufficient when cohort consistency is important?
- Four hypotheses are tested using Bonferroni control at family-wise \(\alpha=0.05\). What per-test threshold applies, and what adjusted p-value corresponds to an unadjusted p-value of \(0.02\)?
- A random-effects analysis reports a pooled 95% confidence interval. Does that interval generally describe the range containing effects in 95% of future cohorts? Explain.
- A study’s replication rule requires a matching direction and adjusted \(p<0.05\). The estimate has the matching direction, but its adjusted p-value is \(0.08\). What should the report conclude?
Solutions. (1) The pooled estimate can conceal the difference between the cohort estimates; report both estimates with intervals and a heterogeneity summary, then explain the pooled result. (2) The per-test threshold is \(0.05/4=0.0125\). The adjusted p-value is \(\min(4(0.02),1)=0.08\). (3) No. The confidence interval estimates uncertainty about the mean effect under the random-effects model; a prediction interval, when supportable, addresses the range of effects in a future cohort and is generally wider. (4) The direction condition is met, but the adjusted-significance condition is not. The result does not meet the full stated replication rule; report the estimate, interval, and failed condition rather than calling it successful or treating the null as established.